TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization

Cell Cycle

Volumn 12, Issue 6, 2013, Pages 889-898

  Bell, Jessica L ^a   Malyukova, Alena ^a   Kavallaris, Maria ^a   Marshall, Glenn M ^a,b   Cheung, Belamy B ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

Cancer; Cell cycle; Cyclin D1; EBBP; Localization; Neuroblastoma; p27; Proliferation; TRIM16

Indexed keywords

PROTEIN; TRIPARTITE MOTIF PROTEIN 16; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENICITY; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL NUCLEUS; CELL PROLIFERATION; CONCENTRATION RESPONSE; CYTOPLASM; DELETION MUTANT; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION;

EID: 84875173298     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23825     Document Type: Article

References (30)

1. Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 2005; 27:1147-57; PMID:16237670; http://dx.doi.org/10.1002/bies.20304
2. Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer 2011; 11:792-804; PMID:21979307; http://dx.doi.org/10.1038/nrc3139
3. Liu HLC, Golder-Novoselsky E, Seto MH, Webster L, McClary J, Zajchowski DA. The novel estrogenresponsive B-box protein (EBBP) gene is tamoxifen-regulated in cells expressing an estrogen receptor DNA-binding domain mutant. Mol Endocrinol 1998; 12:1733-48; PMID:9817599; http://dx.doi.org/10. 1210/me.12.11.1733
4. Cheung BB, Bell J, Raif A, Bohlken A, Yan J, Roediger B, et al. The estrogen-responsive B box protein is a novel regulator of the retinoid signal. J Biol Chem 2006; 281:18246-56; PMID:16636064; http://dx.doi.org/10.1074/jbc. M600879200
5. Raif A, Marshall GM, Bell JL, Koach J, Tan O, D'andreti C, et al. The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoidresistant cancer cells via effects on histone acetylation. Cancer Lett 2009; 277:82-90; PMID:19147277; http://dx.doi.org/10.1016/j.canlet.2008.11.030
6. Marshall GM, Bell JL, Koach J, Tan O, Kim P, Malyukova A, et al. TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells. Oncogene 2010; 29:6172-83; PMID:20729920; http://dx.doi.org/10.1038/onc.2010.340
7. Cheung BB, Koach J, Tan O, Kim P, Bell JL, D'andreti C, et al. The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro. J Pathol 2012; 226:451-62; PMID:22009481; http://dx.doi.org/10.1002/path. 2986
8. Galderisi U, Jori FP, Giordano A. Cell cycle regulation and neural differentiation. Oncogene 2003; 22:5208-19; PMID:12910258; http://dx.doi.org/10. 1038/sj.onc.1206558
9. Watanabe Y, Watanabe T, Kitagawa M, Taya Y, Nakayama Ki, Motoyama N. pRb phosphorylation is regulated differentially by cyclin-dependent kinase (Cdk) 2 and Cdk4 in retinoic acid-induced neuronal differentiation of P19 cells. Brain Res 1999; 842:342-50; PMID:10526130; http://dx.doi.org/10.1016/S0006-8993(99) 01844-2
10. Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 1999; 98:859-69; PMID:10499802; http://dx.doi.org/10.1016/S0092-8674(00)81519-6
11. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79:551-5; PMID:7954821; http://dx.doi.org/10.1016/0092-8674(94)90540-1
12. Chan JYH, Li L, Fan YH, Mu ZM, Zhang WW, Chang KS. Cell-cycle regulation of DNA damageinduced expression of the suppressor gene PML. Biochem Biophys Res Commun 1997; 240:640-6; PMID:9398618; http://dx.doi.org/10.1006/bbrc.1997.7692
13. Everett RD, Lomonte P, Sternsdorf T, van Driel R, Orr A. Cell cycle regulation of PML modification and ND10 composition. J Cell Sci 1999; 112:4581-8; PMID:10574707
14. Bell JL, Malyukova A, Holien JK, Koach J, Parker MW, Kavallaris M, et al. TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members. PLoS ONE 2012; 7:e37470; PMID:22629402; http://dx.doi.org/10. 1371/journal.pone.0037470
15. Kurki S, Latonen L, Laiho M. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. J Cell Sci 2003; 116:3917-25; PMID:12915590; http://dx.doi.org/10.1242/jcs.00714
16. Dellaire G, Bazett-Jones DP, Dellaire G, Bazett-Jones DP. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 2004; 26:963-77; PMID:15351967; http://dx.doi.org/10.1002/bies.20089
17. Bernardi R, Papa A, Pandolfi PP. Regulation of apoptosis by PML and the PML-NBs. Oncogene 2008; 27:6299-312; PMID:18931695; http://dx.doi.org/10.1038/ onc.2008.305
18. Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC, de Thé H. PML induces a novel caspase-independent death process. Nat Genet 1998; 20:259-65; PMID:9806544; http://dx.doi.org/10.1038/3068
19. Borriello A, Pietra VD, Criscuolo M, Oliva A, Tonini GP, Iolascon A, et al. p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation. Oncogene 2000; 19:51-60; PMID:10644979; http://dx.doi.org/10.1038/sj.onc.1203231
20. Beer HD, Munding C, Dubois N, Mamie C, Hohl D, Werner S. The estrogen-responsive B box protein: a novel regulator of keratinocyte differentiation. J Biol Chem 2002; 277:20740-9; PMID:11919186; http://dx.doi.org/10.1074/jbc.M111233200
21. Hansford LM, Thomas WD, Keating JM, Burkhart CA, Peaston AE, Norris MD, et al. Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification. Proc Natl Acad Sci USA 2004; 101:12664-9; PMID:15314226; http://dx.doi.org/10.1073/pnas.0401083101
22. Bergmann E, Wanzel M, Weber A, Shin I, Christiansen H, Eilers M. Expression of P27(KIP1) is prognostic and independent of MYCN amplification in human neuroblastoma. Int J Cancer 2001; 95:176-83; PMID:11307151; http://dx.doi.org/10.1002/1097-0215(20010520)95:3<176::AID-IJC1030>3.0. CO;2-Z
23. Niu MY, Ménard M, Reed JC, Krajewski S, Pratt MAC. Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells. Oncogene 2001; 20:3506-18; PMID:11429697; http://dx.doi.org/10.1038/sj.onc.1204453
24. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54:1812-7; PMID:8137296
25. Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B, et al. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol 1998; 18:3212-22; PMID:9584162
26. Mateyak MK, Obaya AJ, Sedivy JM. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 1999; 19:4672-83; PMID:10373516
27. Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 1997; 16:2985-95; PMID:9214616; http://dx.doi.org/10.1093/emboj/16.11.2985
28. Cao T, Borden KL, Freemont PS, Etkin LD. Involvement of the rfp tripartite motif in proteinprotein interactions and subcellular distribution. J Cell Sci 1997; 110:1563-71; PMID:9247190
29. Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN, et al. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci 1999; 112:381-93; PMID:9885291
30. Loinder K, Söderström M. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR). J Steroid Biochem Mol Biol 2004; 91:191-6; PMID:15336696; http://dx.doi.org/10.1016/j.jsbmb.2004.04.006